Shinichi Oka

Statistics

Publications

308

Citations

13.2K

H-Index

Active since

1973

Affiliations

National Center for Global Health and Medicine(Current)

Kumamoto University

Saitama International Medical Center

National Institute of Infectious Diseases

The University of Tokyo

Shinichi Oka is an author at National Center for Global Health and Medicine specializing in infectious diseases, antiretroviral therapy, and life sciences.

ORCID

Publications per year

1973–2023

308

Publications

308

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Paul E. Sax, David A. Wohl, Michael T. Yin et al. · The Lancet · 2015 · 598 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Adaptation of HIV-1 to human leukocyte antigen class I

Yuka Kawashima, Katja Pfafferott, John Frater et al. · Nature · 2009 · 470 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 464 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens

K. Tsuchiya, Hiroyuki Gatanaga, Natsuo Tachikawa et al. · Biochemical and Biophysical Research Communications · 2004 · 272 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26

Hiroyuki Gatanaga, Tsunefusa Hayashida, K. Tsuchiya et al. · Clinical Infectious Diseases · 2007 · 222 citations

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 308